Biotech iQ
@biotechiq.bsky.social
Tech entrepreneur, science nerd, and biotech investor for over 20 years. I don't offer financial advice, only my own opinions.
https://www.biotechiq.net/about-biotech-iq/
https://www.biotechiq.net/about-biotech-iq/
$EOLS (L) pre-announced $79.0M unaudited 2024Q4 revenue, above my and market estimates as revenue growth rebounded in Q4. The company has several tailwinds heading into 2025 including an earlier-than-expected launch of Evolysse now expected in 2025 Q2. Updated Biotech iQ Q4 Scorecard:
#biotech
#biotech
January 25, 2025 at 10:27 PM
$EOLS (L) pre-announced $79.0M unaudited 2024Q4 revenue, above my and market estimates as revenue growth rebounded in Q4. The company has several tailwinds heading into 2025 including an earlier-than-expected launch of Evolysse now expected in 2025 Q2. Updated Biotech iQ Q4 Scorecard:
#biotech
#biotech
$AUTL (L) Quick comparison of Aucatzyl vs. Blincyto vs. Tecartus:
January 25, 2025 at 10:02 PM
$AUTL (L) Quick comparison of Aucatzyl vs. Blincyto vs. Tecartus: